Personal tools

Coexpression cluster:C475: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C475_CD14_Basophils_CD14CD16_Peripheral_CD133_large_immature |id=C475 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C475_CD14_Basophils_CD14CD16_Peripheral_CD133_large_immature
|full_id=C475_CD14_Basophils_CD14CD16_Peripheral_CD133_large_immature
|id=C475
|id=C475
|ontology_enrichment_celltype=CL:0000766!3.88e-30!76;CL:0002057!7.10e-28!42;CL:0002009!1.33e-27!65;CL:0000557!2.07e-27!71;CL:0002194!1.83e-26!63;CL:0000576!1.83e-26!63;CL:0000040!1.83e-26!63;CL:0000559!1.83e-26!63;CL:0000860!2.63e-26!45;CL:0000738!3.66e-26!140;CL:0000839!1.75e-23!70;CL:0002087!6.26e-20!119;CL:0002031!3.50e-18!124;CL:0000763!8.12e-18!112;CL:0000049!8.12e-18!112;CL:0000037!3.80e-17!172;CL:0000566!3.80e-17!172;CL:0002032!3.24e-15!165;CL:0000837!3.24e-15!165;CL:0000988!4.42e-15!182;CL:0000134!2.08e-10!358;CL:0002320!1.10e-09!365;CL:0002393!1.36e-07!9;CL:0002397!1.36e-07!9;CL:0000451!9.85e-07!10
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!1.64e-25!102;UBERON:0003061!1.64e-25!102;UBERON:0002371!1.40e-24!80;UBERON:0001474!1.67e-24!86;UBERON:0002193!4.25e-22!112;UBERON:0004765!1.80e-19!101;UBERON:0001434!1.80e-19!101;UBERON:0002405!7.09e-14!115;UBERON:0003081!6.57e-10!216;UBERON:0002384!6.39e-09!375;UBERON:0000926!1.14e-07!448;UBERON:0004120!1.14e-07!448;UBERON:0006603!1.14e-07!448;UBERON:0002204!1.40e-07!167
}}
}}

Revision as of 14:52, 21 May 2012


Full id: C475_CD14_Basophils_CD14CD16_Peripheral_CD133_large_immature



Phase1 CAGE Peaks

Hg19::chr10:23727673..23727693,-p@chr10:23727673..23727693
-
Hg19::chr11:10921401..10921434,-p@chr11:10921401..10921434
-
Hg19::chr11:10921615..10921626,+p@chr11:10921615..10921626
+
Hg19::chr11:68847955..68847972,-p@chr11:68847955..68847972
-
Hg19::chr12:125110878..125110906,-p@chr12:125110878..125110906
-
Hg19::chr17:73291353..73291364,+p@chr17:73291353..73291364
+
Hg19::chr17:76837499..76837540,-p@chr17:76837499..76837540
-
Hg19::chr17:81039657..81039682,-p@chr17:81039657..81039682
-
Hg19::chr5:56021776..56021780,-p@chr5:56021776..56021780
-
Hg19::chr6:159541174..159541187,+p@chr6:159541174..159541187
+
Hg19::chr6:88428781..88428805,-p@chr6:88428781..88428805
-
Hg19::chr7:2778019..2778050,+p@chr7:2778019..2778050
+
Hg19::chr8:16054579..16054589,-p@chr8:16054579..16054589
-
Hg19::chr9:110250629..110250642,-p7@KLF4
Hg19::chr9:110250651..110250662,-p11@KLF4
Hg19::chr9:110250697..110250738,-p2@KLF4
Hg19::chr9:110250834..110250861,+p@chr9:110250834..110250861
+
Hg19::chr9:110250881..110250903,+p@chr9:110250881..110250903
+
Hg19::chr9:97416545..97416564,-p@chr9:97416545..97416564
-
Hg19::chrX:152991865..152991874,+p@chrX:152991865..152991874
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
myeloid leukocyte3.88e-3076
CD14-positive, CD16-negative classical monocyte7.10e-2842
macrophage dendritic cell progenitor1.33e-2765
granulocyte monocyte progenitor cell2.07e-2771
monopoietic cell1.83e-2663
monocyte1.83e-2663
monoblast1.83e-2663
promonocyte1.83e-2663
classical monocyte2.63e-2645
leukocyte3.66e-26140
myeloid lineage restricted progenitor cell1.75e-2370
nongranular leukocyte6.26e-20119
hematopoietic lineage restricted progenitor cell3.50e-18124
myeloid cell8.12e-18112
common myeloid progenitor8.12e-18112
hematopoietic stem cell3.80e-17172
angioblastic mesenchymal cell3.80e-17172
hematopoietic oligopotent progenitor cell3.24e-15165
hematopoietic multipotent progenitor cell3.24e-15165
hematopoietic cell4.42e-15182
mesenchymal cell2.08e-10358
connective tissue cell1.10e-09365
intermediate monocyte1.36e-079
CD14-positive, CD16-positive monocyte1.36e-079
dendritic cell9.85e-0710
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.64e-25102
blood island1.64e-25102
bone marrow1.40e-2480
bone element1.67e-2486
hemolymphoid system4.25e-22112
skeletal element1.80e-19101
skeletal system1.80e-19101
immune system7.09e-14115
lateral plate mesoderm6.57e-10216
connective tissue6.39e-09375
mesoderm1.14e-07448
mesoderm-derived structure1.14e-07448
presumptive mesoderm1.14e-07448
musculoskeletal system1.40e-07167


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.